Article: Kumetrix Enters Into Agreement With Bayer Relating to Blood-Glucose Monitoring Device for Diabetics.

Silicon Micro-Needle Device Permits Painless Method to Test Blood

UNION CITY, Calif., April 24 /PRNewswire/ --

Kumetrix, Inc., a privately held medical device company, today announced it has entered into an agreement with Bayer Corporation's Business Group Diagnostics relating to Kumetrix's silicon micro-needle device for diabetic blood glucose monitoring.

Under the terms of the agreement, Kumetrix will provide Bayer exclusive rights to further evaluate the Kumetrix silicon micro-needle technology for commercial application in diabetic blood glucose monitoring. Bayer and Kumetrix contemplate working towards creating additional commercial ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!